Today: July 23, 2017, 8:54 am
  
Business

Crown Bioscience Announces Record Breaking Growth With First 2017 Quarter Results

PR-Inside.com: 2017-05-19 14:04:02

SANTA CLARA, Calif., May 19, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, announces continued growth in 2017 with dramatic first quarter results.

In Q1 17 revenue reached NT$493 million, a 34% YOY (year-over-year) growth. Gross margin reached 49.3% with EPS (earnings per share) of NT$0.13. With the strong demand for Oncology and Immunology therapy, the company anticipates sustained revenue growth and increased profitability through 2017.

To achieve this growth CrownBio leveraged its existing platforms of patient-derived xenograft (PDX) and cell line derived xenograft pharmacology models, and expanded immuno-oncology translatable models while broadening the portfolio offering to inflammatory disease. This extensive portfolio supports the therapeutic continuum of Oncology, Cardiovascular, Metabolic, and Inflammatory disease research.

"The double and triple digit growth regionally, proves CrownBio's global reach and strong local presence is servicing our client base with sound scientific offerings," said Laurie Heilmann, SVP of Global Strategy, Business Development and Marketing, "Our Immuno-Oncology, Cardiovascular, and Metabolic translatable models, along with strong performance in Europe, US, and the Western APAC region were significant contributors to the growth."

Continued diversity across their service offerings, while remaining client centric, has enabled CrownBio to secure confidence by demonstrating growth in 75% of the top tier pharma companies. "CrownBio brings clarity to drug discovery with end to end solutions that help recognize the next clinical candidate sooner," said Dr. Jean-Pierre Wery, CEO. "We will further advance preclinical and clinical research through accelerating development of technologies, including biomarker discovery and precision diagnosis that are needed to bring the right molecule to market."

For more information on CrownBio's commitment to furthering the field of oncology and metabolic disease drug discovery, visit www.crownbio.com.

About Crown Bioscience Inc.

Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.

Media Enquiries:

Jody Barbeau
Crown Bioscience Inc. marketing@crownbio.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Crown Bioscience Inc. via Globenewswire




# 533 Words
Related Articles
More From The Author
Citi Announces Awards for the Tech for [..]
Citi (NYSE: C) today announced the three award recipients from Citi’s Tech for Integrity Challenge (T4I) Demo Day in Dublin, [..]
AKQA Announces Young Lions Cyber Brazil Winners
AKQA Art Director Andrea Souza and Copywriter Caio Muratore have been named the 2017 Young Lions Cyber Brazil winners by [..]
MetLife Announces Uniphore as Winner of collab
LumenLab, MetLife’s Singapore-based innovation center, this evening announced Uniphore as the winner of its inaugural corporate-startup [..]
Industry First: VistaJet Abolishes Positioning Fees Globally
To free its Program customers from expensive ferry fees, company will never charge them for positioning an aircraft anywhere in [..]
PIKO TARO to Serve as Ambassador of [..]
WAKUWAKU JAPAN CORPORATION (headquartered in Minato Ward, Tokyo, Masafumi Kawanishi, President and CEO) has named PIKO TARO, the [..]
 
More From Business
Rakhi.giftalove.com: The Most Apt Space to Send [..]
Rakhi.giftalove.com is one the best platform to send Rakhi to Hyderabad and to any other location of the world. In [..]
Sendrakhi.com Delivering Rakhis throughout the Country
New Delhi, Delhi, 20-July-17: Online shopping for Raksha Bandhan has caught up a great pace with more and more people [..]
28th Hong Kong Book Fair Opens with [..]
HONG KONG, July 19, 2017 - (ACN Newswire) - The 28th Hong Kong Book Fair opened today and will run [..]
Rakhi.in High Achievers in the International Market
New Delhi, Delhi, 18-July-17: Rakhi.in has tackled a lot of challenges head on to provide its customers with the best [..]
Max Lami Skate Wear Clothing Announces Pop-up [..]
After a successful brand launch on July 10th 2017, Max Lami Clothing is now looking to open pop –up shops [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.